CN Patent

CN112789042A — 用于治疗由毒蕈碱受体激活所缓解的障碍的组合物和方法

Assigned to Karuna Therapeutics Inc · Expires 2021-05-11 · 5y expired

What this patent protects

本文提供了一种口服药物组合物，所述口服药物组合物包含多个具有核心的呫诺美林珠，所述核心包含呫诺美林或其盐；以及多个具有核心的曲司氯胺珠，所述核心包含曲司氯胺盐。

USPTO Abstract

本文提供了一种口服药物组合物，所述口服药物组合物包含多个具有核心的呫诺美林珠，所述核心包含呫诺美林或其盐；以及多个具有核心的曲司氯胺珠，所述核心包含曲司氯胺盐。

Drugs covered by this patent

Patent Metadata

Patent number: CN112789042A
Jurisdiction: CN
Classification: —
Expires: 2021-05-11
Drug substance claim: No
Drug product claim: No
Assignee: Karuna Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.